Bened Biomedical Co.,LtD is a leading company focused on pharma-grade probiotics for neuro health, supported by clinical studies of the gut-brain axis. Their pioneering achievements in probiotic development emphasize their cutting-edge neurological benefits, with a focus on developing pharma-grade psychobiotics that have significant effects on physical and mental health. Their product, PS128™, is the first neurobiotic in Asia clinically proven to benefit mood, neurodevelopment, and neurodegeneration, particularly for patients with autism spectrum disorder (ASD) and Parkinson’s disease (PD). Another strain they offer is HT-PS23™, which possesses distinctive antidepressant and anxiolytic effects while optimizing physical and psychological health. With 43+ patents granted worldwide, they are currently serving more than 40 countries and are focused on expanding their reach even further. Founded in 2015 and headquartered in Taiwan, Bened Biomedical Co.,LtD is a promising player in the field of neuro health probiotics, with substantial potential for growth and global impact.
